Patients at highest risk include those in the dose-escalation phase, experiencing active gastrointestinal symptoms (nausea, vomiting, bloating), those with known gastroparesis, or those taking concurrent medications that further delay gastric emptying (such as opioids)
By enhancing your nervous systems natural rhythms and restoring healthy movement, this supplement offers sustainable supportespecially valuable if youre in it for the long game with GLP-1 therapy
Watanabe Y, Kawai K, Ohashi S, Yokota C, Suzuki S, Yamashita K
This concentration balances ease of injection with precise dose delivery
Clinical experience suggests these patients should start preventive acid-suppressing medication (usually a PPI) at the same time they begin semaglutide, rather than waiting for symptoms to develop